Dr. Margaret Bridget McEntegart, MD

Dr. McEntegart practices at Trustees of Columbia University in the City of New York in New York, New York.

Dr. McEntegart's NPI, 1669780201, was assigned on September 16, 2010. Dr. McEntegart graduated from University of Glasgow Faculty of Medicine in 1997. Dr. McEntegart holds New York license 315189.

Dr. McEntegart's primary practice is Trustees of Columbia University in the City of New York, at 630 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 342-5155.

Dr. McEntegart's primary practice is Trustees of Columbia University in the City of New York in New York, New York. Dr. McEntegart is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. McEntegart to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McEntegart practices, 2 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. McEntegart's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. McEntegart is licensed in New York.

Dmand AI lists angioplasty, cardiac arrhythmia, cardiac catheterization, chronic hypertension, circulation problems, congestive heart failure, coronary artery disease and heart attack among the conditions Dr. McEntegart treats.

CMS data shows 334 Medicare services from Dr. McEntegart across 9 procedure codes in 2024, for 105 Medicare patients. Medicare paid $41,002 for them.

CMS counts 105 Medicare patients who saw Dr. McEntegart in 2024. The largest group is 75 to 84, with 44 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McEntegart's median patient age at 71, with 31% women.

In 2024, Dr. McEntegart wrote 15 Medicare Part D claims. 93% of them were for generic drugs. They cover 2 drugs, with $299 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. McEntegart for performance year 2024, reported through an alternative payment model (APM). Dr. McEntegart accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McEntegart as offering telehealth. CMS counts 110 procedures of coronary angioplasty and stenting by Dr. McEntegart, more than 97% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 158 papers to Dr. McEntegart, published from 2006 to 2025. 2016 was the busiest year, with 13. The most frequent topics are Percutaneous Coronary Intervention, Coronary Angiography and Coronary Artery Disease. Dr. McEntegart has published most often in Catheter Cardiovasc Interv. Dr. McEntegart's most frequent co-authors are Ajay J. Kirtane, MD, Khaldoon Alaswad, MD and Kevin J. Croce, MD.

Dmand AI links Dr. McEntegart to 6 clinical trials. 2 are still active or recruiting. Conditions studied include Microvascular Angina, Angina Pectoris, Variant and Arterial Occlusive Diseases. NHS National Waiting Times Centre Board sponsors the most, 4.

CMS Open Payments shows 171 general payments to Dr. McEntegart from 15 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 42% of the total. ShockWave Medical, Inc paid the most, $82,876. It also lists 5 research payments totaling $319 in 2023.

Dr. McEntegart graduated from University of Glasgow Faculty of Medicine in 1997.

Dr. McEntegart is in network with 15 carriers, including Elevance, Aetna and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.